GSK Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated March 24, 2025, serves as a report of a foreign private issuer. The filing announces the publication of the Notice of the 2025 Annual General Meeting (AGM) and related governance documents.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance notice and does not contain financial performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Actions
- AGM Details: The 2025 AGM is scheduled for Wednesday, May 7, 2025, at 2:30 pm at The Landmark London, 222 Marylebone Road, London.
- Participation: The meeting will be held in person and broadcast live for electronic shareholder participation.
- Document Availability: The 2025 AGM Notice, Proxy Form, and GSK Share Value Plan rules have been published on the company website and submitted to the UK Financial Conduct Authority (FCA) for inspection.
Key Facts for Investor Verification
- Verify the date and location of the 2025 AGM (May 7, 2025, London).
- Confirm access to the 2025 AGM Notice and Proxy Form via the company website or FCA National Storage Mechanism.
- Note that this filing contains no financial results; investors should refer to the most recent Form 20-F or quarterly earnings release for financial data.